BCL2 and breast carcinoma: As SLIRP expression has been demonstrated both in breast cancer cell lines and primary tissues (http://www.proteinatlas.org), we extended the results obtained in the lung adenocarcinoma model to a breast adenocarcinoma cell line with low level of endogenous bcl-2, such as MDA-MB-231.